Low Dose Oral Methotrexate in Pediatric Crohn’s Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
Learn more about:
Related Clinical Trial
Non-Invasive Monitoring Through Bowel Ultrasound in Paediatric Inflammatory Bowel Disease Study
Exercise Training in Youth With Inflammatory Bowel Disease
Usefulness of Contrast-enhanced Ultrasound (CEUS) in Crohn’s Disease Pediatric Patients
Peer Mentoring to Improve Self-management in Youth With IBD
Mission is Remission®: How Can a Disease Self-management Website Change Care?
Trial of Enhanced Pre-Consent Discussion
Clinical Study of TA-650 in Pediatric Patients With Crohn’s Disease
TOPIT; Trough Level Optimized Pediatric Inflammatory Bowel Disease Therapy: A Multicenter Study Comparing Effectiveness of Trough Level Optimized Infliximab Maintenance Therapy With Standard Dosing Regimen of Pediatric Patients With Crohn’s Disease
Post-Marketing Surveillance of Humira in Korean Pediatric Crohn’s Disease (CD) Patients Under the “New-Drug Re-examination”
Clinical Hypnosis in Pediatric Crohn’s Disease
Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn’s Disease (CD)
Low Dose Oral Methotrexate in Pediatric Crohn’s Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy
PediCRaFT: Pediatric Crohn’s Disease Fecal Transplant Trial
FMT in Pediatric Crohn’s Disease
Efficacy and Safety of Top-down Therapy in Pediatric Crohn’s Disease